HOE642 + anti-PD-1 combination therapy reduced the CD4+ Treg cell counts while increased tumor infiltration of CD4+IFNγ+ T cells and CD8+ IFNγ+ T cells in GL26 tumors. The gene discussed is CD4; the disease is neoplasm.